• Vaccine Name: 2011–2012 trivalent inactivated vaccine (A/California/7/09 (H1N1,), A/Perth /16/2009 (H3N2), and B/Brisbane/60/2008).
• Target Pathogen: Influenza virus
• Target Disease: Influenza (flu)
• Vaccine Ontology ID: VO_0004810
• Type: Inactivated or "killed" vaccine
• Status: Licensed
• Host Species for Licensed Use: Baboon
• Immunization Route: Intramuscular injection (i.m.)

Human Response

• Vaccination Protocol: Volunteer recruitment and vaccination protocols for this study were approved by the Vanderbilt Institutional Review Board (IRB#111030 “CLR-03 2011-Immune Cells and Soluble Factors from Healthy Donor”). After obtaining written informed consent, thirty one subjects were enrolled in this study. Twenty-nine subjects provided 90mL blood samples to develop our phenotyping and cell sorting protocols and to establish baseline blood profiling information; for these purposes, twenty three subjects provided a single blood sample, and six subjects provided four samples over subsequent days on the same schedule as proposed for vaccinated subjects. Once the cell sorting pipeline was in place, two subjects were vaccinated with a single dose of 2011–2012 seasonal trivalent inactivated influenza vaccine (TIV) (strains included: A/California/7/09 (H1N1,), A/Perth /16/2009 (H3N2), and B/Brisbane/60/2008). Blood samples (90mL) from the two vaccinated subjects were processed prior to vaccination (day 0) and at days 1, 3, and 7 post-vaccination for downstream RNA-seq and quantitative proteomics analysis. (Hoek et al., 2015)
• Host CXCR3 response
  • Description: CXCR3, the receptor for CXCL10/IP-10, was significantly up-regulated in both PBMC and sorted B cell samples after TIV vaccination(Hoek et al., 2015).
  • Detailed Gene Information: Click Here.
• Host TNFRSF17 response
  • Description: The 2011-2012 TIV vaccine induced upregulation of TNFRSF17 in sorted B cell samples from both subjects 7 days after vaccination (Hoek et al., 2015).
  • Detailed Gene Information: Click Here.
• Host XBP1 response
  • Description: The 2011-2012 TIV vaccine induced upregulation of XBP1 in sorted B cell samples from both subjects 7 days after vaccination
  • Detailed Gene Information: Click Here.